Secondly, there has been an increasing trend in the proportion of patients testing positive for FIT at the 10 μg/g threshold: FIT positivity has increased from 11.7% in September 2021 to 18.8% in February 2024 (Fig. 2 A).
← all excerpts
External validation of the COLOFIT colorectal cancer risk prediction model in the Oxford-FIT dataset: the importance of population characteristics and clinically relevant evaluation metrics.
1
—
—